Szántó Magdolna

1.

Molnár, P., Demény, M. Á., Várkonyi, B., Polgár, Z., Pór, Á., Kovács, I., Szegedi, A., Szöllősi, A. G., Szántó, M.: The clinically applied PARP inhibitor talazoparib ameliorates imiquimod-induced psoriasis in mice without reducing skin inflammation.
Front. Pharmacol. 16, 1-11, (article identifier: 1519066), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Pharmacology (2024)

Q1 Pharmacology (medical) (2024)

2.

Szántó, M., Yélamos, J., Bai, P.: Specific and shared biological functions of PARP2-is PARP2 really a lil' brother of PARP1?.
Expert Rev. Mol. Med. 26, 1-21, (article identifier: 13), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Molecular Biology

Q1 Molecular Medicine

3.

Antal, D., Pór, Á., Kovács, I., Dull, K., Póliska, S., Ujlaki, G., Demény, M. Á., Szöllősi, A. G., Kiss, B. K., Szegedi, A., Bai, P., Szántó, M.: PARP2 promotes inflammation in psoriasis by modulating estradiol biosynthesis in keratinocytes.
J. Mol. Med. (Berl). 101 (8), 987-999, 2023.

doi DEA WoS Scopus

Journal metrics:

D1 Drug Discovery

Q1 Genetics (clinical)

Q1 Molecular Medicine

4.

Antal, D., Pór, Á., Kovács, I., Dull, K., Póliska, S., Ujlaki, G., Demény, M. Á., Szöllősi, A. G., Kiss, B. K., Szegedi, A., Bai, P., Szántó, M.: PARP2 promotes inflammation in sporiasis by modulating estradiol biosynthesis in keratinocytes.
In: FEBS Advanced Lecture Course: PARP 2023: Research on the family of poly(ADP-ribose) polymerases; Book of Abstracts. Ed.: Andreja Mikoc, Ivan Matic, Ruder Boskovic Institue, Hvar, 60, 2023. ISBN: 9789537941468

DEA

5.

Antal, D., Alimohammadi, S., Bai, P., Szöllősi, A. G., Szántó, M.: Antigen-Presenting Cells in Psoriasis.
Life (Basel). 12 (2), 1-10, (article identifier: 234), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q2 Ecology, Evolution, Behavior and Systematics

Q2 Paleontology

Q2 Space and Planetary Science

6.

Antal, D., Janka, E. A., Szabó, J., Szabó, I. L., Szegedi, A., Gáspár, K., Bai, P., Szántó, M.: Culture-based analyses of skin bacteria in lesional moist, and unaffected dry and sebaceous skin regions of hidradenitis suppurativa patients.
J. Eur. Acad. Dermatol. Venereol. 36 (9), e731-e733, 2022.

doi DEA WoS Scopus

Journal metrics:

D1 Dermatology

Q1 Infectious Diseases

7.

Antal, D., Pór, Á., Dull, K., Kovács, I., Szegedi, A., Bai, P., Szántó, M.: Poly(ADP-ribose) polymerase (PARP)-2 promotes inflammation in psoriasis by regulating estradiol biosynthesis in keratinocytes.
J. Invest. Dermatol. 142 (12), S237, 2022.

DEA

8.

Szántó, M., Gupte, R., Kraus, W. L., Pacher, P., Bai, P.: PARPs in lipid metabolism and related diseases.
Prog. Lipid Res. 84, 1-24, (article identifier: 101117), 2021.

doi DEA WoS Scopus

Journal metrics:

D1 Biochemistry

Q1 Cell Biology

9.

Kiss, B. K., Szántó, M., Hegedűs, C., Antal, D., Szödényi, A., Márton, J., Méhes, G., Virág, L., Szegedi, A., Bai, P.: Poly(ADP-ribose) polymerase-1 depletion enhances the severity of inflammation in an imiquimod-induced model of psoriasis.
Exp. Dermatol. 29 (1), 79-85, 2020.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q1 Dermatology

Q2 Molecular Biology

10.

Jankó, L., Sári, Z., Kovács, T., Kis, G., Szántó, M., Antal, M., Juhász, A. G., Bai, P.: Silencing of PARP2 blocks autophagic degradation.
Cells. 9 (2), 1-21, 2020.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous)

11.

Szántó, M., Bai, P.: The role of ADP-ribose metabolism in metabolic regulation, adipose tissue differentiation and metabolism.
Genes Dev. 34 (5-6), 321-340, 2020.

doi DEA WoS Scopus

Journal metrics:

D1 Developmental Biology

D1 Genetics

12.

Szántó, M., Oláh, A., Szöllősi, A. G., Tóth, K. F., Páyer, E., Czakó, N., Pór, Á., Kovács, I., Zouboulis, C. C., Kemény, L. V., Bíró, T., Tóth, I. B.: Activation of TRPV3 inhibits lipogenesis and stimulates production of inflammatory mediators in human sebocytes: a putative contributor to dry skin dermatoses.
J. Invest. Dermatol. 139 (1), 250-253, 2019.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry

Q1 Cell Biology

D1 Dermatology

Q1 Molecular Biology

13.

Szántó, M., Dózsa, A., Antal, D., Szabó, K., Kemény, L. V., Bai, P.: Targeting the gut-skin axis - Probiotics as new tools for skin disorder management?.
Exp. Dermatol. 28 (11), 1210-1218, 2019.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry

Q1 Dermatology

Q2 Molecular Biology

14.

Márton, J., Péter, M., Balogh, G., Bódi, B., Vida, A., Szántó, M., Bojcsuk, D., Jankó, L., Bhattoa, H. P., Gombos, I., Uray, K., Horváth, I., Török, Z., Bálint, B. L., Papp, Z., Vígh, L., Bai, P.: Poly(ADP-ribose) polymerase-2 is a lipid-modulated modulator of muscular lipid homeostasis.
Biochim. Biophys. Acta. Mol. Cell Biol. Lipids. 1863 (11), 1399-1412, 2018.

doi DEA

Journal metrics:

Q1 Cell Biology

Q1 Molecular Biology

15.

Oláh, A., Alam, M., Chéret, J., Kis, G., Hegyi, Z., Szántó, M., Bai, P., Lerchner, J., Bíró, T., Paus, R.: CB1 is a novel regulator of epidermal mitochondrial functions.
J. Invest. Dermatol. 137 (Suppl.), S210, 2017.

DEA

16.

Abdul-Rahman, O., Kristóf, E., Doan-Xuan, Q. M., Vida, A., Nagy, L., Horváth, A., Simon, J., Maros, T. M., Szentkirályi, I., Palotás, L., Debreceni, T., Csizmadia, P., Szerafin, T., Fodor, T., Szántó, M., Tóth, A., Kiss, B. K., Bacsó, Z., Bai, P.: AMP-Activated Kinase (AMPK) Activation by AICAR in Human White Adipocytes Derived from Pericardial White Adipose Tissue Stem Cells Induces a Partial Beige-Like Phenotype.
PLoS One. 11 (6), e0157644, 2016.

doi DEA WoS Scopus

Journal metrics:

Q1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

17.

Fodor, T., Szántó, M., Abdul-Rahman, O., Nagy, L., Dér, Á., Kiss, B. K., Bai, P.: Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1.
PLoS One. 11 (2), 1-16, 2016.

doi DEA WoS Scopus

Journal metrics:

Q1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

Q1 Medicine (miscellaneous)

18.

Kiss, B. K., Szántó, M., Szklenár, M., Brunyánszki, A., Marosvölgyi, T., Sárosi, E., Remenyik, É., Gergely, P., Virág, L., Decsi, T., Rühl, R., Bai, P.: Poly(ADP) ribose polymerase-1 ablation alters eicosanoid and docosanoid signaling and metabolism in a murine model of contact hypersensitivity.
Mol. Med. Rep. 11 (4), 2861-2867, 2015.

doi DEA

Journal metrics:

Q3 Biochemistry

Q3 Cancer Research

Q3 Genetics

Q3 Molecular Biology

Q3 Molecular Medicine

Q3 Oncology

19.

Szántó, M., Bai, P.: Poly-(ADP-ribose) polymerases and mitochondria.
In: Mitochondrial Diseases and Therapy. Szerk.: V.Vijaya Padma, SM Group, Irving, 1-9, 2015.

DEA

20.

Szántó, M., Brunyánszki, A., Márton, J., Vámosi, G., Nagy, L., Fodor, T., Kiss, B. K., Virág, L., Gergely, P., Bai, P.: Deletion of PARP-2 induces hepatic cholesterol accumulation and decrease in HDL levels.
Biochim. Biophys. Acta. Mol. Basis Dis. 1842 (4), 594-602, 2014.

doi DEA

Journal metrics:

Q1 Molecular Biology

Q1 Molecular Medicine

21.

Nagy, L., Docsa, T., Szántó, M., Brunyánszki, A., Hegedűs, C., Márton, J., Kónya, B., Virág, L., Somsák, L., Gergely, P., Bai, P.: Glycogen Phosphorylase Inhibitor N-(3,5-Dimethyl-Benzoyl)-N'-(β-D-Glucopyranosyl)Urea Improves Glucose Tolerance under Normoglycemic and Diabetic Conditions and Rearranges Hepatic Metabolism.
PLoS One. 8 (7), e69420-, 2013.

doi DEA

Journal metrics:

D1 Agricultural and Biological Sciences (miscellaneous)

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)

D1 Medicine (miscellaneous)

22.

Szántó, M., Brunyánszki, A., Kiss, B. K., Nagy, L., Gergely, P., Virág, L., Bai, P.: Poly(ADP-ribose) polymerase-2: emerging transcriptional roles of a DNA-repair protein.
Cell. Mol. Life Sci. 69 (24), 4079-4092, 2012.

doi DEA

Journal metrics:

Q1 Cell Biology

D1 Cellular and Molecular Neuroscience

Q1 Molecular Biology

D1 Molecular Medicine

D1 Pharmacology

23.

Bai, P., Cantó, C., Brunyánszki, A., Huber, A., Szántó, M., Cen, Y., Yamamoto, H., Houten, S. M., Kiss, B. K., Oudart, H., Gergely, P., Menissier-de, M. J., Schreiber, V., Sauve, A. A., Auwerx, J.: PARP-2 regulates SIRT1 expression and whole-body energy expenditure.
Cell Metab. 13 (4), 450-460, 2011.

doi DEA

Journal metrics:

D1 Cell Biology

D1 Molecular Biology

D1 Physiology

24.

Szántó, M., Rutkai, I., Hegedűs, C., Czikora, Á., Rózsahegyi, M., Kiss, B. K., Virág, L., Gergely, P., Tóth, A., Bai, P.: Poly(ADP-ribose) polymerase-2 depletion reduces doxorubicin-induced damage through SIRT1 induction.
Cardiovasc. Res. 92 (3), 430-438, 2011.

doi DEA

Journal metrics:

D1 Cardiology and Cardiovascular Medicine

D1 Physiology

D1 Physiology (medical)

25.

Brunyánszki, A., Hegedűs, C., Szántó, M., Erdélyi, K., Kovács, K., Schreiber, V., Gergely, S., Kiss, B. K., Szabó, É., Virág, L., Bai, P.: Genetic ablation of PARP-1 protects against oxazolone-induced contact hypersensitivity by modulating oxidative stress.
J. Invest. Dermatol. 130 (11), 2629-2637, 2010.

doi DEA

Journal metrics:

Q1 Biochemistry

Q1 Cell Biology

D1 Dermatology

Q1 Molecular Biology

Publication list